A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer

[1]  Appendix A1 , 2006, Guidelines for Air & Ground Transport.

[2]  M. Seymour.  Fluorouracil, oxaliplatin and CPT-11 (irinotecan), use and sequencing (MRC FOCUS): A 2135-patient randomized trial in advanced colorectal cancer (ACRC) , 2005 .

[3]  D. Cunningham,et al.  Final results of a randomized phase III study evaluating the addition of oxaliplatin first line to 5-FU followed by irinotecan at progression in advanced colorectal cancer (LIFE study) , 2005 .

[4]  M. Buyse,et al.  Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  O. Holmberg,et al.  Intensity modulated radiation therapy (IMRT) may reduce the oesophageal toxicity of hypofractionated accelerated 3-D radiation for non small cell lung carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  T. Conroy,et al.  Quality of life in patients with advanced colorectal cancer: what has been learnt? , 2003, European journal of cancer.

[7]  陆星华,et al.  Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis , 2001 .

[8]  P. Simmonds,et al.  Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis , 2000, BMJ : British Medical Journal.

[9]  D. Kerr,et al.  Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: non-randomised comparison of weekly versus four-weekly schedules--less pain, same gain. QUASAR Colorectal Cancer Study Group. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  D. Jonker,et al.  Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials , 2000, British Journal of Cancer.

[11]  L. Påhlman,et al.  Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  H. Wieand,et al.  Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  W. Scheithauer,et al.  Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. , 1993, BMJ.

[14]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[15]  Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  P. Piedbois.  Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S. Pyrhönen,et al.  Phase II study of epirubicin sequential methotrexate and 5-fluorouracil for advanced colorectal cancer. , 1992, European journal of cancer.

[18]  Y. Rustum.  Toxicity and antitumor activity of 5‐fluorouracil in combination with leucovorin. Role of dose schedule and route of administration of leucovorin , 1989, Cancer.

[19]  A. Coates,et al.  On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy. , 1983, European journal of cancer & clinical oncology.

[20]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.

[21]  A. Dobson,et al.  Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. , 1981, Journal of chronic diseases.

[22]  M. Baum,et al.  EVALUATION OF QUALITY OF LIFE IN PATIENTS RECEIVING TREATMENT FOR ADVANCED BREAST CANCER , 1976, The Lancet.

[23]  R. Salama.  IMMUNITY AND CYSTIC FIBROSIS. , 1965, Lancet.